NOTVMEDIUM SIGNALFINANCIAL10-K

NOTV showed meaningful improvement in profitability metrics with substantially higher gross profit and reduced operating losses, though operating cash flow deteriorated and debt service costs increased significantly.

The company demonstrated notable operational improvements with gross profit growing substantially and operating losses meaningfully reduced, suggesting better cost management or pricing power. However, the deterioration in operating cash flow and increased interest expense indicate ongoing financial strain and higher borrowing costs that could pressure future performance.

Comparing 2025-12-05 vs 2024-12-04View on EDGAR →
FINANCIAL ANALYSIS

NOTV's financial performance showed mixed signals with substantially higher gross profit and meaningfully reduced operating losses indicating improved operational efficiency. However, operating cash flow deteriorated notably while interest expense grew significantly, reflecting increased debt burden and cash management challenges. The combination of better profitability metrics alongside weaker cash generation and higher debt service costs suggests a company in transition with improving operations but persistent financial pressures.

FINANCIAL STATEMENT CHANGES
Gross Profit
P&L
+65.4%
$18.2M→$30.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Operating Income
P&L
+64.2%
-$86.4M→-$30.9M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

R&D Expense
P&L
-57.4%
$950K→$405K

R&D spending cut 57.4% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
-53.6%
-$6.8M→-$10.5M

Operating cash flow fell 53.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Interest Expense
P&L
+44.8%
$29.7M→$43.0M

Interest expense surged 44.8% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
+36.7%
-$108.4M→-$68.6M

Net income grew 36.7% — bottom-line growth signals improving overall business health.

Stockholders Equity
Balance Sheet
-20.2%
$170.5M→$136.0M

Equity decreased 20.2% — buybacks or losses reducing book value, monitor solvency ratios.

Current Assets
Balance Sheet
+19.1%
$163.4M→$194.6M

Current assets grew 19.1% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2025-12-05
PRIOR — 2024-12-04
ADDED
As of November 21, 2025, 34,367,251 of the registrant s common shares were outstanding.
We have provided a summary of some of these risks below, with more information in Part I, Item 1A.
We have significant indebtedness, which may impair our ability to raise capital or impact our ability to service our debt.
Our management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective as of September 30, 2025 and as of prior dates due to material weaknesses in internal control over financial reporting.
Our business, results of operations, financial condition, including the carrying value of certain of our assets, and cash flows have been, and may continue to be, adversely affected by our dependence on the importation of non-human primates ("NHPs") from suppliers located outside the U.S., particularly from certain countries in Southeast Asia and Africa, legal issues related to these suppliers, increased costs associated with trade and economic factors, including tariffs, and any inability to diversify our suppliers located outside the U.S.
+7 more — sign up free →
REMOVED
As of November 15, 2024, 26,015,129 of registrant s common shares were outstanding.
If any of the events or circumstances described in Part I, Item 1A.
Our sales of non-human primates ("NHPs") have decreased significantly in recent periods, which adversely affected our business, financial condition and results of operations, and this trend may continue.
Our business, results of operations, financial condition, including the carrying value of certain of our assets, and cash flows have and may continue to be adversely affected by our dependence on the importation of NHPs from suppliers located outside the U.S., particularly from communist countries in Southeast Asia, legal issues related to these suppliers and any inability to diversify our suppliers located outside the U.S.
We have incurred significant additional indebtedness, which may impair our ability to raise further capital or impact our ability to service our debt.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →